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Abstract 
In a global context of marine biological resource overexploitation, a better upgrading 
of fish and shellfish biomass is a challenge for the 21
st
 century. One of the main and 
promising issues will be the production of marine bio-ingredients using enzymatic 
hydrolysis. This paper presents the key steps in the production of enzymatic hydrolysates, 
such as (i) enzymatic treatment for the bioconversion of solid discards, and more 
particularly, use of proteases, (ii) quantification of the proteolysis extend and procedures 
of quality-control and (iii) identification of biological activity, using in vitro and in vivo 
methods. In the last part, examples of marine, commercially available functional foods or 
nutraceutical ingredients carrying bioactive properties are presented in order to 
demonstrate the interest of biotechnological exploitation of marine resources. 
Key words: marine by-products; enzymatic process; degree of hydrolysis; bioactive peptides; functional food; 
nutraceutical ingredients. 
Résumé 
Dans un contexte global de surexploitation des ressources biologiques marines, la 
valorisation des biomasses de poissons, mollusques et crustacés représente un enjeu 
majeur pour le 21
ème
 siècle. Une des voies les plus prometteuses sera la production de bio-
ingrédients marins utilisant l'hydrolyse enzymatique. Ce document présente les étapes 
principales de la production des hydrolysats enzymatiques, telles que (i) le traitement 
enzymatique pour la bioconversion des déchets solides et, plus particulièrement, 
l'utilisation des protéases, (ii) la mesure des taux de protéolyse et les procédures de 
contrôle-qualité, et (iii) l’identification des activités biologiques à l’aide de méthodes de 
dosage in vitro et in vivo. Dans la dernière partie sont présentés des exemples d’aliments 
fonctionnels d’origine marine commercialisés ou d’ingrédients nutraceutiques porteurs de 
propriétés bioactives, démontrant ainsi l'intérêt de l'exploitation biotechnologique des 
ressources marines. 
Mots clefs: Co-produits marins; process enzymatiques; degré d'hydrolyse; peptides bioactifs; aliments 
fonctionnels; ingrédients nutraceutiques. 
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1. Introduction 
Out of the estimated 140 million tons of fish and shellfish produced each year worldwide, only one part is 
used for direct human consumption. This part varies from 50 to 70 % according to the type of species and the 
possibilities of processing. The remainder includes carcasses, frames, heads, intestinal organs and also a large 
amount of edible fish. In the past, these by-products have often been dumped or used without treatment for 
animal feed or as fertilizer. However, due to the worldwide decline of fish stocks, a better use of by-catch and 
by-products is deemed necessary.  
Today, directing by-products more to fish hydrolysates and active ingredients is the ‘big dream’ of marine 
biotechnology industry: these products are low in volume but with high value, and there is a tremendous 
potential for these innovative molecules (Thorkelsson et al., 2008).  
Indeed, enzymatic processes applied to protein and lipid recovery in fish or shellfish discards render it 
possible to produce a large and diversified range of products for different applications (Guérard, 2007). Among 
the published works, many of them deal with enzyme technology (Aspmo et al., 2005; Batista et al., 2009; 
Chabeaud et al., 2009) or fractionation of hydrolysates using membrane processes (Bourseau et al., 2009). A 
review by Kristinsson & Rasco (2000) pointed out the development of enzyme technologies for producing new 
feeding stuffs, similar to that already obtained by enzymatic hydrolysis of milk and plant proteins. In addition, 
recent studies have revealed the wide range of FPH applications, as peptone ingredient in microbial growth 
media, or as new sources of bioactive peptides related to immune defence, opioid, antioxidant and 
antihypertensive effects. 
Strategic and technical considerations for enzymatic bioconversion of solid discards  
When generating peptide fractions from marine by-products using an enzyme-assisted hydrolysis, 3 main 
factors appear to be the most important on the release of peptides with biological activity: 
• The nature of the matrices 
• The choice of protease  
• The extend of hydrolysis  
 
Before dealing with the choice of enzyme, it is advisable to specify that among the marine by-products, 
numerous substrates are potential candidates to be transformed into FPH, in conditions whereby (i) they are 
available in sufficient quantity for a transformation at industrial scale and (ii) the by-products are of as good 
quality as that of the products intended for human consumption in particular in terms of freshness and weak 
microbial contamination (Guérard et al., 2008). Concerning the choice of enzyme, there is no standard 
methodology, however this step is very important if the product has to exhibit predetermined properties such 
as functional or bioactive properties. Because numerous enzymatic preparations are commercially available, it 
is neither easy nor realistic to predict which enzyme should be ‘the best one’ to generate peptide fractions with 
targeted biological activities. Table 1 summarises information on the characteristics of the most popular 
enzymes used in many documented studies for by-product solubilisation and suggests treatment times for 
inactivation at given pH and temperatures. All of them are endopeptides (e.g. Alcalase®, Neutrase,® 
Protamex®) except Flavourzyme® which is a mixture of exopeptidase/endopeptidase. The introduction of new 
proteases capable of degrading bitter peptides (such as Flavourzyme® from Novozymes) has contributed to 
eliminate the problem of bitter hydrolysate bitterness that often occurs with moderate enzymatic hydrolysis. 
 
Table 1. Characteristics of most popular proteases used for by-product solubilisation (adapted from 
www.novozymes.com and www.dsm.com). 
 
Treatment times for inactivation at 
given pH and temperature  
 
Optimum 
pH 
Optimum  
temperature 
(°C) 
pH T(°C) Time Max.  % DH 
Alcalase® 
2,4L 6.5 - 8.5 60 4-8 50-85 30-10 15-25 
Flavourzyme® 5.0 - 7.0 50-55 6-8 90 10 - 
Neutrase ® 5.5 - 7.5 45-55 4-7 50-80 30-4 10-15 
ProtamexTM 7 - 8 50 4-8 50-85 30-10 10-20 
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Figure 1 outlines the main steps of the process in the enzymatic solubilisation of marine by-products. 
Briefly, solid discards are ground and suspended in water, then pH is adjusted before enzyme is added to the 
slurry. In some cases, the raw material is first heated in order to denature the endogenous proteases. The 
reaction is allowed to proceed from under one hour to several hours, depending on the activity of the enzyme 
employed, temperature of the process and other factors. The added enzymes are then inactivated by pH or 
heat treatment at the end of the batch reaction. After separation of solids, the aqueous layer is clarified, and 
then dryied or concentrated. Finally, biochemical assays are performed on the resulting hydrolysate. In some 
cases, a continuous process including enzymatic hydrolysis coupled with membrane technology will allow a 
repeated use of enzymes in the bioreactor. 
 
Figure 1. Main steps of the process in the enzymatic solubilisation of marine by-products. 
 
2.Quantification of the proteolysis extent 
The hydrolysis reaction should be carefully controlled in order to maintain a uniform quality of the end 
products. The Degree of Hydrolysis (DH), which is defined as the percentage of cleaved peptide bonds, is 
commonly used to describe hydrolysis of food protein and serves as the controlling parameter for the 
hydrolysis reaction. Several methods have been applied to the quantification of proteolysis extent but one of 
the most popular methods is based on the evaluation of DH according to the pH-stat method (for a review, see 
Guérard et al., 2005; Kristinsson, 2007). The pH-stat technique consists in adding base for titration of the 
released α-amino groups, thus maintaining the pH constant (at pH values above 6.5). Equation (1), which 
relates the DH to alkali consumption, is as follows (Alder-Nissen, 1982): 
100111% x
h
x
MP
xxxNbBDH
totα
=             (1) 
Where B is the volume (mL) of base added, Nb is the normality of the base (mM), α is the average degree of 
dissociation of the α-NH2 groups, MP is the gram of protein in the reaction mixture, htot is the total number of 
peptide bonds (meq g
-1
). The principle of the pH-stat method has been used by many workers for kinetic 
studies and the DH gives a measurement of the enzyme hydrolytic efficiency.  
3. Control of the reproducibility of the enzymatic hydrolysis based on the study of molecular 
weight distribution  
In the generation of peptide fractions with biological activities using an enzyme-assisted hydrolysis, a crucial 
question is: How to guarantee a consistent composition of hydrolysate peptide fractions in all batches? Protein 
hydrolysates can be characterized according to the size of peptides released during enzymatic hydrolysis. This 
procedure using Size Exclusion Chromatography (SEC) is complementary to the methods implemented for the 
quantification of DH. In our opinion, it is not used as frequently as it should be. SEC is a useful tool when it is 
necessary to check that hydrolysates can be produced in a repeatable manner (e.g. for the production of 
peptides with biological activities), whatever the production scale is (lab scale, or pilot/industrial scale). In our 
lab, we have selected the Superdex® Peptide HR 10/300 (Amersham Biosciences) which is characterized by a 
fractionation range corresponding to most of peptides exhibiting biological activity, ranging from 100 to 7000 
Da. The separation conditions were optimized and resulted in using a mixture 30% (ACN): 70 % (H2O-TFA 0.1 %) 
Guérard et al., (2010) J. Sci. Hal. Aquat., 2:21-27 
24 
as mobile phase (Guérard et al., 2001). However, the fractionation range values can only serve as guidelines, 
especially because the elution behaviour of peptides in non-dissociating media is influenced by adsorption and 
aggregation and because of the underestimation of small peptides and free amino acids. The advantage of 
working in FPLC mode is the rate of fractionation, as chromatographic separation is performed in less than one 
hour compared to several hours when using low pressure chromatography (data not shown).  
4. Examples of commercially available hydrolysates carrying bioactive properties 
The potential of bioactive peptides derived from dietary proteins has aroused a lot of scientific interest and 
attention. Bioactive peptides have been defined as specific protein fragments that may exert regulative 
activities on body functions, in particular, reducing the risk of disease or enhancing a certain physiological 
function (Meisel, 2007). They are low in molecular weight, and easily absorbable and digestible. However, the 
presence of bioactive peptides in marine by-product hydrolysates is less documented than bioactive peptides 
derived from milk or soy protein. Recent studies have identified a number of biological activities in 
hydrolysates from marine substrates such as fish bone, skin, internal organ, shellfish and crustacean. 
Researchers have identified that FPH possessed hormonal-like peptides to accelerate calcium absorption and 
provide satiety such as calcitonin/CGRP-like peptides and cholecystokinin-like peptides (Cudennec et al., 2008) 
; (Martinez-Alvarez et al., 2007) and other biological activities such as immunostimulant (Yang et al., 2009), 
antioxidant (Ranathunga et al., 2006; Klompong et al., 2007; Klompong et al., 2008) anti-hypertensive (He et 
al., 2007 ; Qian et al., 2007; Nii et al., 2008), antimicrobial effects or could be used as calcium supplement. It 
can be observed that among scientific publications related to biological activities of marine by-product 
hydrolysates, anti-hypertensive and antioxidant peptides are by far the best documented.  
4.1. Lowering blood pressure 
For example, hypertension is a major problem threatening people health in the world: about 20 % of the 
world’s adult population is suffering from hypertension. Therefore, any substance such as captopril (a synthesis 
chemical drug) or natural ACE inhibitory peptides can finally lead to the drop of blood pressure. There are many 
scientific publications showing that peptides obtained from enzymatic treatment of marine substrates such as 
shrimp hydrolysates (He et al., 2008) and Alaska Pollack hydrolysates (Byun & Kim, 2001) are able to inhibit 
ACE. Peptide sequences are known, ranging from 2 to 15 amino acid residues. Some commercial products 
containing fish protein hydrolysates able to reduce blood pressure have been approved by authorities, such as 
Japanese authorities in the case of the Katsuobushi oligopeptide made by hydrolysis of bonito muscle (a 
Thermolysin digest: Leu-Lys-Pro-Asn-Met). Several human clinical trials have confirmed this formula’s efficacy 
with no adverse effects. These products can be used on their own or with other supplements and prescription 
medications.  
4.2. Reducing oxidative stress 
Some protein hydrolysates have been reported to exhibit antioxidant properties (i.e. the capacity to reduce 
oxidative stress). The term antioxidant is defined as ’any substance that, when present at low concentration 
compared to that of oxidizable substrate, significantly delays or inhibits oxidation of that substrate‘. 
Antioxidant can act at different levels in an oxidative sequence by (i) retarding the formation of free radicals 
(preventive antioxidants) or (ii) by introducing substances that compete for the existing radicals and remove 
them from the reaction medium (chain breaking antioxidants). As a matter of fact, antioxidative activities result 
from a complex peptidic mixture including inactive, antioxidant and/or prooxidant compounds and represent 
the average activity of all peptides within the hydrolysate. Peptide sequences of antioxidant peptides are well-
documented, ranging from 5 to more than 15 amino acid residues, from substrates such as Tuna backbone 
hydrolysed using trypsin (Je et al., 2007), Hoki skin gelatine treated with trypsin (Mendis et al., 2005). 
Many commercial products for nutraceutical applications are available, such as: 
• Stabilium 200, an Atlantic fish autolysate (www.yalacta.com) and PROTIZEN®, a white fish hydrolysate 
(www.copalis.fr), both carrying relaxing effect. 
• Nutripeptin®, a cod hydrolysate, for lowering glycemic index (www.copalis.fr). 
• Seacure®, a fish fillet hydrolysate obtained by fermentation using a marine microorganism, mainly 
composed of dipeptide and tripeptide, for improving gastrointestinal health 
(www.propernutrition.com (USA)). 
• Fortidium LIQUAMEN®, a fish autolysate of white fish (Molva molva) (www.biothalassol.com) 
exhibiting multi effects such as Reducing oxidative stress, Lowering glycemic index and Anti-stress. 
This product also contains fish oil and vegetal oil. 
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6. Conclusion 
The upgrading of seafood by-products is currently a rapidly developing area as shown by the numerous 
scientific papers published worldwide on this topic for the past ten years. This can be explained with the 
increasing awareness that by-products contain valuable components which can be utilized for conversion into 
useful and high-value products. In this review, we have attempted to demonstrate that enzymatic processes 
applied to marine by-product solubilisation offer a rapid and reproducible method for the recovery of high 
valuable compounds.  
However, the first biggest challenge is ensuring good quality of raw material in terms of low microbial 
charge and low contaminant content such as dioxin, PCB, heavy metals, good stability to oxidation, and 
consistent composition in all batches resulting from enzymatic treatment of marine biomasses. The second one 
is documenting and verifying health claims. According to Thorkelsson et al., (2008) the focus must be on more 
in vivo animal and eventually clinical human studies. The fact that most companies in this area are small makes 
this a difficult task because costs can be very high for those types of trials.  
How to succeed? 
• By setting up a fully integrated chain for the production of value added compounds 
derived from marine resources, embracing the total seafood production chain system 
from stocks to market. 
• By helping the companies to take advantage of the use of modern biotechnological tools 
and to contribute to a diversification of the activities derived from marine biomass 
exploitation. 
• By developing transfer of knowledge from research centres to enterprises. 
Some of these actions are currently being undertaken within the European Union ERDF - Atlantic Area 
Programme", Biotecmar project (contract n°: 2008-1/032) which objective is to help SMEs of the Atlantic Area 
in making the necessary steps for supporting a fully-integrated and environmentally compatible chain for 
underexploited Atlantic marine resources.  
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